A Phase IB/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
Phase of Trial: Phase I/II
Latest Information Update: 13 Jan 2018
At a glance
- Drugs Pazopanib (Primary) ; Docetaxel; Gemcitabine
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 26 Feb 2015 Last checked against the Robert H. Lurie Comprehensive Cancer Center record.
- 17 Dec 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
- 05 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.